Sugarloaf Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-119
| Closed | -$15.7K | – | 743 |
|
|
2022
Q4 | $15.7K | Sell |
119
-19
| -14% | -$2.5K | ﹤0.01% | 440 |
|
|
2022
Q3 | $17K | Hold |
138
| – | – | ﹤0.01% | 437 |
|
|
2022
Q2 | $16K | Buy |
138
+1
| +0.7% | +$116 | ﹤0.01% | 438 |
|
|
2022
Q1 | $18K | Sell |
137
-1
| -0.7% | -$131 | ﹤0.01% | 415 |
|
|
2021
Q4 | $21K | Hold |
138
| – | – | 0.01% | 418 |
|
|
2021
Q3 | $22K | Sell |
138
-250
| -64% | -$39.9K | 0.01% | 403 |
|
|
2021
Q2 | $63K | Sell |
388
-702
| -64% | -$114K | 0.02% | 243 |
|
|
2021
Q1 | $96 | Buy |
1,090
+940
| +627% | +$83 | 0.03% | 189 |
|
|
2020
Q4 | $23K | Buy |
150
+70
| +88% | +$10.7K | 0.01% | 354 |
|
|
2020
Q3 | $11K | Hold |
80
| – | – | ﹤0.01% | 445 |
|
|
2020
Q2 | $11K | Buy |
+80
| New | +$11K | ﹤0.01% | 434 |
|